WO2020103439A1 - Low-protein serum-free cell culture medium - Google Patents

Low-protein serum-free cell culture medium

Info

Publication number
WO2020103439A1
WO2020103439A1 PCT/CN2019/091341 CN2019091341W WO2020103439A1 WO 2020103439 A1 WO2020103439 A1 WO 2020103439A1 CN 2019091341 W CN2019091341 W CN 2019091341W WO 2020103439 A1 WO2020103439 A1 WO 2020103439A1
Authority
WO
WIPO (PCT)
Prior art keywords
culture medium
cells
protein
acid
cell culture
Prior art date
Application number
PCT/CN2019/091341
Other languages
French (fr)
Chinese (zh)
Inventor
苏恩本
Original Assignee
苏恩本
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 苏恩本 filed Critical 苏恩本
Publication of WO2020103439A1 publication Critical patent/WO2020103439A1/en

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018Culture media for cell or tissue culture
    • C12N5/0037Serum-free medium, which may still contain naturally-sourced components
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/05Inorganic components
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/05Inorganic components
    • C12N2500/10Metals; Metal chelators
    • C12N2500/20Transition metals
    • C12N2500/24Iron; Fe chelators; Transferrin
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/30Organic components
    • C12N2500/32Amino acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/30Organic components
    • C12N2500/38Vitamins
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30Hormones
    • C12N2501/33Insulin
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/998Proteins not provided for elsewhere

Definitions

  • the present application relates to the technical field of cell culture, in particular, to a low-protein serum-free cell culture medium.
  • Cell culture is to simulate cell growth environment in vitro to achieve cell in vitro culture.
  • Animal cell in vitro culture technology is widely used in the field of cell and tissue physiology, biochemistry and pharmacological activity research and the industrial production of biological products such as antibodies, hormones and vaccines.
  • the preparation technology of cell culture medium is a vital part of cell culture technology in vitro.
  • the traditional serum-containing medium contains various growth factors, plasma proteins, peptides and hormones, a large number of components necessary for cell growth and value-added, the serum has large batch-to-batch differences, potential contamination risks, unclear components, and is not conducive to the separation and purification of the target product And it is easy to be infected by viruses and mycoplasma infection.
  • the serum-free medium has a relatively clear composition and a simple preparation process. It can be widely used in the field of modern biotechnology.
  • composition of serum-free medium is relatively clear, the quality is consistent and the protein content is low, which is conducive to improving the stability of cell product production and making the cell product easy to purify. Optimized so that different cells can each continue to grow at a high density in the environment most conducive to their growth or expression of the product of interest.
  • the commercial serum-free medium is mainly imported, which is expensive, and the formula is confidential, which is not conducive to the optimization of the subsequent cultivation process.
  • Some scientific research Institutions or R & D units are only for development and self-use. Therefore, independent research and development of serum-free medium that can support the rapid growth of hybridoma cells and high expression of monoclonal antibodies, and related process optimization and amplification to meet the needs of a large number of monoclonal antibodies expressed are critical to the target protein industrialization.
  • different cell lines have their unique nutritional needs, and no one culture medium will fully meet the needs of all cell lines or maximize the expression potential of the cells. Therefore, independent research and development and optimization of specific cell lines Personalized serum-free medium is also an important part of large-scale cell culture.
  • the serum medium has the problems of large batch-to-batch variation, potential contamination risk, unclear composition, is not conducive to the separation and purification of the target product and is easily infected.
  • the protein-free serum-free medium with a completely clear chemical composition is highly targeted. In other words, it is not very versatile. Generally, one medium is only suitable for the cultivation of a certain type of cell. In addition, the cells are in a completely serum-free medium Easily affected by physical mechanical factors and chemical factors.
  • the purpose of the present application is to overcome the shortcomings of the above medium and prepare a low protein serum-free cell culture medium.
  • the present application relates to a low-protein serum-free cell culture medium, which contains a basic physiological buffer mixture and protein components;
  • the protein component includes bovine serum albumin, transferrin, and insulin, and the total added amount of the protein component does not exceed 30 mg / L.
  • the medium is suitable for animal cell culture, especially mammalian cell culture.
  • FIG. 1 is a growth curve of hybridoma cells 1C3 cultured in serum-free medium in an embodiment of the present application
  • FIG. 2 is a graph showing the change curve of glucose concentration, cell density, cell viability, and monoclonal antibody expression of hybridoma cells DF92 cultured in serum-free medium according to an example of the present application with culture time;
  • 3 is a graph showing changes in glucose concentration, cell density, cell viability, and monoclonal antibody expression of hybridoma cells 1A4 cultured using Gibco serum-free medium in the prior art with culture time;
  • FIG. 4 is a graph showing the change curve of glucose concentration, cell density, cell viability, and monoclonal antibody expression of hybridoma cells 1A4 fermented and cultured with serum-free medium in an example of the present application with the culture time.
  • the present application relates to a low-protein serum-free cell culture medium, which contains a basic physiological buffer mixture and protein components;
  • the protein component includes bovine serum albumin, transferrin, and insulin, and the total added amount of the protein component does not exceed 30 mg / L.
  • the total added amount of the protein component is 18-30 mg / L, and 20 mg / L, 22 mg / L, 24 mg / L, 26 mg / L, and 28 mg / L can also be selected.
  • the protein component includes bovine serum albumin 10.0-20.0 mg / L, transferrin 2.5-5.5 mg / L, and insulin 5.0-12.0 mg / L;
  • the protein component includes bovine serum albumin 13.0-17.0 mg / L, transferrin 4.5-5.5 mg / L, and insulin 9.0-11.0 mg / L;
  • the basic physiological buffer mixture is based on DMEM / F12 as a basic medium, and one or more of amino acids, vitamins, inorganic salts, trace elements, and lipids are added;
  • the volume ratio of DMEM to F12 in DMEM / F12 is 0.8-1.2;
  • the volume ratio of DMEM to F12 in the DMEM / F12 is 1.
  • the lipid is selected from the group consisting of:
  • the lipid is selected from the group consisting of:
  • the lipid is selected from the group consisting of:
  • the amino acid is selected from the group consisting of:
  • the amino acid is selected from the group consisting of:
  • Arginine 40-54mg / L cystine 9-11mg / L, histidine 11-14mg / L, isoleucine 16-20mg / L, leucine 16-20mg / L, lysine 16 -20mg / L, methionine 5-6mg / L, phenylalanine 11-13mg / L, threonine 19-21mg / L, tryptophan 3-5mg / L, tyrosine 11-14mg / L, Valine 19-21mg / L, Glycine 5-6mg / L, Alanine 6-8mg / L, Asparagine 9-11mg / L, Aspartic acid 9-11mg / L, Glutamate 9 -11mg / L, proline 6-8mg / L, serine 6-8mg / L.
  • the vitamin is selected from the group consisting of:
  • Choline chloride calcium pantothenate, folic acid, nicotinamide, pyridoxal hydrochloride, riboflavin, thiamine, inositol;
  • the concentration of the above vitamins may be selected from 0.7-1.8 mg / L, and may also be selected from 0.8 mg / L, 0.9 mg / L, 1.0 mg / L, 1.1 mg / L, 1.2 mg / L, 1.3 mg / L, 1.4mg / L, 1.5mg / L, 1.6mg / L, 1.7mg / L; the concentration of each vitamin can be the same or different.
  • the vitamin is selected from the group consisting of:
  • Choline chloride 0.7-1.8mg / L calcium pantothenate 0.7-1.8mg / L, folic acid 0.7-1.8mg / L, nicotinamide 0.7-1.8mg / L, pyridoxal hydrochloride 0.7-1.8mg / L, nuclear yellow It is 0.7-1.8mg / L, thiamine 0.7-1.8mg / L and inositol 0.7-1.8mg / L.
  • the vitamin is selected from the group consisting of:
  • Choline chloride 1.0-1.4mg / L calcium pantothenate 0.8-1.4mg / L, folic acid 1.0-1.4mg / L, nicotinamide 1.0-1.4mg / L, pyridoxal hydrochloride 1.0-1.4mg / L, nuclear yellow 1.0-1.4mg / L, thiamine 1.0-1.4mg / L, inositol 1.0-1.4mg / L.
  • the inorganic salt is selected from the group consisting of:
  • the inorganic salt is selected from the group consisting of:
  • the culture medium contains one or more trace elements selected from the group consisting of:
  • the trace element is selenium, added in the form of selenite, and the content is 3-8 ⁇ g / L.
  • the basic physiological buffer mixture further includes a buffer and / or an anti-shear protection agent
  • the buffer is sodium bicarbonate 1.0-1.8g / L and Hepes3.2-4.5mg / L;
  • the anti-shear protection agent is Pluronic F-68700-2000 mg / L.
  • the present application also relates to a method of culturing cells, comprising: culturing the cells in the medium as described above;
  • the cells are pluripotent stem cells, embryonic stem cells, bone marrow stromal cells, hematopoietic progenitor cells, lymphatic stem cells, bone marrow stem cells, T cells, B cells, macrophages, liver cells, pancreatic cells, cancer cells And cell lines;
  • cell line is selected from the group consisting of:
  • the cell is a hybridoma cell.
  • a hybridoma cell is an infinitely passaged cell capable of secreting a single unique antibody.
  • the monoclonal antibody secreted by it is widely used in vaccine production, in vitro diagnosis, and biomedicine.
  • the medium enables hybridoma cells to grow normally and express monoclonal antibodies under suspension conditions. On the one hand, it meets the needs of monoclonal antibodies in the in vitro diagnostic reagent industry, and on the other hand, it can reduce costs.
  • the hybridoma cell line 1D7 was cultured, and the viable cell density in the culture system was sampled at 72 hours.
  • L16 (45) orthogonal test method referring to relevant literature materials, after screening, 5 types of additives that promote cell culture were determined.
  • the 5 types of additives that promote cell culture were: A, 8 types of lipids; B , 8 vitamins; C, 3 proteins; D, 19 amino acids; E, 7 inorganic salts.
  • the test was based on DMEM / F12 (v / v, 1: 1), and pre-added 6 ⁇ g / L selenite, 1.5g / L sodium bicarbonate and 3.8mg / L Hepes, and Pluronic F-681300mg / L.
  • Orthogonal test method is used to optimize the five selected additives, each factor (A, B, C, D, E) is set to four different concentration levels (1,2,3,4, the concentration of additives contained from low To high).
  • arachidonic acid 10 ⁇ g / L, cholesterol 500 ⁇ g / L, linoleic acid 80 ⁇ g / L, linolenic acid 80 ⁇ g / L, oleic acid 80 ⁇ g / L, palmitoleic acid 50 ⁇ g / L, stearic acid 50 ⁇ g / L, ethanolamine 1000 ⁇ g / L.
  • arachidonic acid 15 ⁇ g / L, cholesterol 1000 ⁇ g / L, linoleic acid 100 ⁇ g / L, linolenic acid 120 ⁇ g / L, oleic acid 120 ⁇ g / L, palmitoleic acid 80 ⁇ g / L, stearic acid 60 ⁇ g / L, ethanolamine 1500 ⁇ g / L.
  • arachidonic acid 25 ⁇ g / L, cholesterol 3000 ⁇ g / L, linoleic acid 180 ⁇ g / L, linolenic acid 200 ⁇ g / L, oleic acid 180 ⁇ g / L, palmitoyl acid 125 ⁇ g / L, stearic acid 100 ⁇ g / L, ethanolamine 2700 ⁇ g / L.
  • B4 choline chloride 1.2mg / L calcium pantothenate 1.2mg / L, folic acid 1.2mg / L, nicotinamide 1.2mg / L, pyridoxal hydrochloride 1.2mg / L, riboflavin 1.2mg / L, thiamine 1.2mg / L, Inositol 1.2mg / L
  • BSA is 5 mg / L
  • transferrin is 2 mg / L
  • insulin is 3 mg / L
  • BSA is 10 mg / L
  • transferrin is 2 mg / L
  • insulin is 5 mg / L
  • BSA is 15 mg / L
  • transferrin is 5 mg / L
  • insulin is 8 mg / L
  • BSA is 15 mg / L
  • transferrin is 5 mg / L
  • insulin is 10 mg / L.
  • iron citrate 18mg / L, sodium pyruvate 75mg / L, calcium chloride 6mg / L, magnesium sulfate 4.5mg / L, potassium chloride 7mg / L, sodium chloride 150mg / L, sodium dihydrogen phosphate 150mg / L
  • the results of orthogonal test showed that among the 16 groups of different combinations of added factors, the combination of A4B4C4D2E1 promoted the density of living cells the most.
  • the size of the range R the influence of each factor on the density of living cells was determined, and the order of the influence of each factor was C> A> D> B> E.
  • the optimal level of the five different additive factors is determined as: A4B4C4D2E1.
  • the concentration of the additive combined at the optimal level was performed as the preferred concentration of the culture medium, followed by the cell culture of Example 2.
  • the above 1C3 cells were expanded and introduced into 4 square flasks. When they were grown to the logarithmic phase, they were inoculated into 1.5L spinner flasks at an initial culture density of about 70 ⁇ 104cells / ml, and then placed at 37 °C, 5% CO2 humidity saturated incubator suspension culture.
  • the lower curve is the growth curve of the hybridoma cells cultured in the serum-free medium described in this application
  • the upper curve is the growth curve of the hybridoma cells cultured in GIBCO Hybridoma-SFM medium.
  • the whole cultivation process lasts 8 days.
  • the culture effect of the serum-free medium described in this application is almost equal to that produced by foreign manufacturers
  • the cultivation effect of the same culture medium, meanwhile, the serum-free culture medium of the present application has relatively low cost, clear chemical composition, and extremely low protein content.
  • the serum-free medium described in the present application is used for the hybridoma cell lines DF92 and 1A4 for fermentor suspension culture, and the medium formula is the same as in Example 2.
  • DF92 uses a 14L bioreactor of Guangzhou Qizhi Biological Company, the initial culture volume is 2L, the control conditions are: Temp 37 ⁇ 0.5 °C, DO 50% ⁇ 5%, pH 6.9 ⁇ 0.1, Stir speed 80rpm, 1A4 uses Applikon 2L biological reaction The initial culture volume is 2L, and the control conditions are: Temp 37 ⁇ 0.5 °C, DO 50% ⁇ 5%, pH 6.9 ⁇ 0.1, Stir speed 80rpm. In the suspension culture process, the fed-batch culture method is adopted.

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Provided is a low-protein serum-free cell culture medium, the culture medium containing a basal physiological buffer mixture and protein components, wherein the protein components comprise bovine serum albumin, transferrin and insulin, and the total addition amount of the protein components does not exceed 30 mg/L. The only three protein components contained in the culture medium are relatively low in content, which is conducive to separating and purifying a product, to improving the quality of the product, to supporting hybridoma cells well, and to increasing the highest cell density and antibody production of hybridoma cells.

Description

低蛋白无血清细胞培养基Low protein serum-free cell culture medium 技术领域Technical field
本申请涉及细胞培养技术领域,具体而言,涉及一种低蛋白无血清细胞培养基。The present application relates to the technical field of cell culture, in particular, to a low-protein serum-free cell culture medium.
背景技术Background technique
细胞培养是通过模拟细胞体内生长环境实现细胞体外培养,动物细胞的体外培养技术被广泛应用于细胞与组织的生理、生化和药理活性研究领域以及抗体、激素和疫苗等生物制品的工业生产领域。其中,细胞培养基的制备技术是细胞体外培养技术中至关重要的一部分。传统含血清培养基虽然含有各种生长因子、血浆蛋白、多肽及激素等大量的细胞生长增值所必需成分,但是血清存在批间差异大、潜在污染风险、成分不明确、不利于目的产物分离纯化,且容易被病毒,产生支原体感染等问题,而无血清培养基由于其组成成分相对明确,制备过程简单,在现代生物技术领域可以广泛应用。Cell culture is to simulate cell growth environment in vitro to achieve cell in vitro culture. Animal cell in vitro culture technology is widely used in the field of cell and tissue physiology, biochemistry and pharmacological activity research and the industrial production of biological products such as antibodies, hormones and vaccines. Among them, the preparation technology of cell culture medium is a vital part of cell culture technology in vitro. Although the traditional serum-containing medium contains various growth factors, plasma proteins, peptides and hormones, a large number of components necessary for cell growth and value-added, the serum has large batch-to-batch differences, potential contamination risks, unclear components, and is not conducive to the separation and purification of the target product And it is easy to be infected by viruses and mycoplasma infection. The serum-free medium has a relatively clear composition and a simple preparation process. It can be widely used in the field of modern biotechnology.
无血清培养基的成分相对明确、质量一致且蛋白质含量低,因而有利于提高细胞产品生产的稳定性并使细胞产品易于纯化,更重要的是可以通过在此基础上对无血清培养基成分的优化,使不同的细胞能各自在最有利其生长或最有利于表达目的产物的环境中持续高密度培养。The composition of serum-free medium is relatively clear, the quality is consistent and the protein content is low, which is conducive to improving the stability of cell product production and making the cell product easy to purify. Optimized so that different cells can each continue to grow at a high density in the environment most conducive to their growth or expression of the product of interest.
关于血清成分替代物促进细胞生长的成分也有很多相关报道。白蛋白是很多无血清培养基的主要添加因子,有调节渗透压,并保护细胞免受机械损伤等作用。李萍等(李萍,蒋琳,黄思扬等,中华仓鼠卵巢工程细胞无血清培养的研究〔J〕微生物学免疫学进展2004,32(4):46~50)实验表明白蛋白还有明显的稳定细胞生长,增加细胞株产物表达量的作用。一般悬浮培养用的无血清培养基都含有牛血清白蛋白。胡雪梅等(胡雪梅,张元兴,氨基酸对中华仓鼠卵巢细胞在无血清培养基中的作用〔J〕华东理工大学学报1996,22(6):283~285)采用正交试验法考察CHO细胞无血清培养中15种氨基酸及其浓度对细胞培养的影响,结果表明添加的精氨酸、亮氨酸、脯氨酸和甲硫氨酸对细胞生长有明显的促进作用,而高浓度的丝氨酸、色氨酸对细胞生长有明显的抑制作用。胰岛素可以促进RNA、蛋白质和脂肪酸的合成,抑制细胞 凋亡,是重要的细胞存活因子。Jan等(Jan L,Haggstrorm L.Specific growth rate as a parameter for tracing growth-limiting substances in animal cell cultures〔J〕.Journal of Biotechnology 1995,42:163~165)认为在批式培养中胰岛素迅速耗尽是细胞比生长速率下降的主要原因。硒在哺乳动物细胞的生长过程中具有明显作用,微量元素硒参与谷胱甘肽过氧化物酶和过氧化物歧化酶的作用过程,消除氧化物酶和氧自由基对细胞的伤害。薛庆善(薛庆善编,体外培养的原理与技术〔M〕.北京科学技术出版社,2001,162~164)指出亚硒酸的适量添加可以促进细胞生长,但是如果浓度过高,则会对细胞产生毒性作用。There are also many related reports on serum component replacements that promote cell growth. Albumin is the main added factor in many serum-free media, which regulates osmotic pressure and protects cells from mechanical damage. Li Ping et al. (Li Ping, Jiang Lin, Huang Siyang, etc., Research on Serum-free Culture of Chinese Hamster Ovary Engineering Cells [J] Advances in Microbiology and Immunology 2004, 32 (4): 46 ~ 50) Experiments show that albumin has obvious Stabilize cell growth and increase cell line product expression. Generally, serum-free medium for suspension culture contains bovine serum albumin. Hu Xuemei et al. (Hu Xuemei, Zhang Yuanxing, Effect of Amino Acids on Chinese Hamster Ovary Cells in Serum-Free Medium [J] Journal of East China University of Science and Technology 1996, 22 (6): 283 ~ 285) Orthogonal test method was used to investigate serum-free CHO cell culture The effect of 15 kinds of amino acids and their concentration on cell culture, the results show that the added arginine, leucine, proline and methionine can obviously promote the growth of cells, while the high concentration of serine and tryptophan Acid has a significant inhibitory effect on cell growth. Insulin can promote the synthesis of RNA, protein and fatty acids, inhibit cell apoptosis, and is an important cell survival factor. Jan et al. (Jan L, Haggstrorm L. Specific growth rate as a parameter) for tracing growth-limiting substances in animal cells [J]. Journal of Biotechnology 1995, 42: 163-165) believes that insulin is rapidly depleted in batch culture It is the main reason why the specific growth rate of cells decreases. Selenium has an obvious role in the growth of mammalian cells. The trace element selenium participates in the process of glutathione peroxidase and peroxide dismutase, eliminating the damage of cells caused by oxidase and oxygen free radicals. Xue Qingshan (Edited by Xue Qingshan, Principles and Techniques of In Vitro Culture [M]. Beijing Science and Technology Press, 2001, 162 ~ 164) pointed out that the proper addition of selenite can promote cell growth, but if the concentration is too high, it will produce cells Toxic effects.
目前商业化无血清培养基主要是以进口为主,价格昂贵、配方保密,不利于后续培养工艺优化,国产无血清培养基厂家不多,且存在市场反馈细胞适应性不强的问题,一些科研机构或研发单位也只是开发自用。因此自主研发可支持杂交瘤细胞快速生长、单克隆抗体高表达量的无血清培养基,并进行相关工艺优化和放大,以满足大量表达单克隆抗体的需求,对目标蛋白产业化至关重要。另外,一般而言,不同的细胞株有其独特的营养需求,没有任何一种培养基会充分满足所有细胞株的需要或发挥细胞的最大表达潜力,因此,自主研发并优化针对特定细胞株的个性化无血清培养基化也是规模细胞培养过程中重要部分。At present, the commercial serum-free medium is mainly imported, which is expensive, and the formula is confidential, which is not conducive to the optimization of the subsequent cultivation process. There are not many domestic serum-free medium manufacturers, and there is a problem that the market feedback cell is not adaptable. Some scientific research Institutions or R & D units are only for development and self-use. Therefore, independent research and development of serum-free medium that can support the rapid growth of hybridoma cells and high expression of monoclonal antibodies, and related process optimization and amplification to meet the needs of a large number of monoclonal antibodies expressed are critical to the target protein industrialization. In addition, in general, different cell lines have their unique nutritional needs, and no one culture medium will fully meet the needs of all cell lines or maximize the expression potential of the cells. Therefore, independent research and development and optimization of specific cell lines Personalized serum-free medium is also an important part of large-scale cell culture.
有鉴于此,特提出本申请。In view of this, this application is hereby submitted.
申请内容Application content
血清培养基存在批间差异大、潜在污染风险、成分不明确、不利于目的产物分离纯化和容易被感染等问题。化学成分完全明确的无蛋白无血清培养基针对性很强,换句话说,就是通用性不高,一般一种培养基仅合适某一种细胞的培养,另外,细胞在完全无血清培养基中容易受到物理机械因素和化学因素的影响。The serum medium has the problems of large batch-to-batch variation, potential contamination risk, unclear composition, is not conducive to the separation and purification of the target product and is easily infected. The protein-free serum-free medium with a completely clear chemical composition is highly targeted. In other words, it is not very versatile. Generally, one medium is only suitable for the cultivation of a certain type of cell. In addition, the cells are in a completely serum-free medium Easily affected by physical mechanical factors and chemical factors.
本申请的目的在于克服以上培养基存在的不足,制备一种低蛋白无血清细胞培养基。The purpose of the present application is to overcome the shortcomings of the above medium and prepare a low protein serum-free cell culture medium.
为了实现本申请的上述目的,特采用以下技术方案:In order to achieve the above purpose of this application, the following technical solutions are specifically adopted:
本申请涉及一种低蛋白无血清细胞培养基,所述培养基包含基础生理缓冲剂混合物和蛋白成分;The present application relates to a low-protein serum-free cell culture medium, which contains a basic physiological buffer mixture and protein components;
所述蛋白成分包括牛血清白蛋白、转铁蛋白、胰岛素,且所述蛋白成分的总添加量不超过30mg/L。The protein component includes bovine serum albumin, transferrin, and insulin, and the total added amount of the protein component does not exceed 30 mg / L.
所述培养基适用于动物细胞,特别是哺乳动物细胞培养。The medium is suitable for animal cell culture, especially mammalian cell culture.
与现有技术相比,本申请的有益效果为:Compared with the prior art, the beneficial effects of this application are:
(1)仅含的三种蛋白类成分含量很低,有利于产物的分离纯化,提高产品的品质;(1) The content of only three protein components is very low, which is conducive to the separation and purification of the product and improves the quality of the product;
(2)成分明确、配制方便,适合于规模生产应用;(2) Clear composition and convenient preparation, suitable for large-scale production and application;
(3)具有较强的通用性;(3) Strong versatility;
(4)能良好地支持杂交瘤细胞,其最高细胞密度和抗体产量均达到或超过GIBCO品牌的商业培养基效果;(4) It can support hybridoma cells well, and its highest cell density and antibody production can reach or exceed the effect of GIBCO brand commercial medium;
(5)支持杂交瘤细胞长期传代培养,无需适应即可直接培养。(5) Support long-term subculture of hybridoma cells, which can be directly cultured without adaptation.
附图说明BRIEF DESCRIPTION
为了更清楚地说明本申请实施例的技术方案,下面将对实施例中所需要使用的附图作简单地介绍,应当理解,以下附图仅示出了本申请的某些实施例,因此不应被看作是对范围的限定,对于本领域普通技术人员来讲,在不付出创造性劳动的前提下,还可以根据这些附图获得其他相关的附图。In order to more clearly explain the technical solutions of the embodiments of the present application, the following will briefly introduce the drawings required in the embodiments. It should be understood that the following drawings only show some embodiments of the present application, so they are not It should be regarded as a limitation on the scope. For those of ordinary skill in the art, without paying any creative work, other related drawings can be obtained based on these drawings.
图1为本申请一个实施例中无血清培养基培养杂交瘤细胞1C3的生长曲线;FIG. 1 is a growth curve of hybridoma cells 1C3 cultured in serum-free medium in an embodiment of the present application;
图2为本申请一个实施例中无血清培养基培养杂交瘤细胞DF92的葡萄糖浓度、细胞密度、细胞活率和单抗表达量随培养时间的变化曲线;2 is a graph showing the change curve of glucose concentration, cell density, cell viability, and monoclonal antibody expression of hybridoma cells DF92 cultured in serum-free medium according to an example of the present application with culture time;
图3为使用现有技术中的Gibco无血清培养基发酵培养杂交瘤细胞1A4的葡萄糖浓度、细胞密度、细胞活率和单抗表达量随培养时间的变化曲线;3 is a graph showing changes in glucose concentration, cell density, cell viability, and monoclonal antibody expression of hybridoma cells 1A4 cultured using Gibco serum-free medium in the prior art with culture time;
图4为本申请一个实施例中无血清培养基发酵培养杂交瘤细胞1A4的葡萄糖浓度、细胞密度、细胞活率和单抗表达量随培养时间的变化曲线。4 is a graph showing the change curve of glucose concentration, cell density, cell viability, and monoclonal antibody expression of hybridoma cells 1A4 fermented and cultured with serum-free medium in an example of the present application with the culture time.
具体实施方式detailed description
在描述本申请的细胞培养物和方法之前,应当理解本申请不限于所述的具体方法和实验条件,因为这类方法和条件可以变动。还应当理解本文中所用的术语其目的仅在于描述具体实施例,并且不意图是限制性的。Before describing the cell cultures and methods of the present application, it should be understood that the present application is not limited to the specific methods and experimental conditions described, as such methods and conditions can vary. It should also be understood that the terminology used herein is for the purpose of describing specific embodiments only and is not intended to be limiting.
本申请涉及一种低蛋白无血清细胞培养基,所述培养基包含基础生理缓冲剂混合 物和蛋白成分;The present application relates to a low-protein serum-free cell culture medium, which contains a basic physiological buffer mixture and protein components;
所述蛋白成分包括牛血清白蛋白、转铁蛋白、胰岛素,且所述蛋白成分的总添加量不超过30mg/L。The protein component includes bovine serum albumin, transferrin, and insulin, and the total added amount of the protein component does not exceed 30 mg / L.
在一些实施方式中,所述蛋白成分的总添加量为18-30mg/L,还可以选择20mg/L、22mg/L、24mg/L、26mg/L、28mg/L。In some embodiments, the total added amount of the protein component is 18-30 mg / L, and 20 mg / L, 22 mg / L, 24 mg / L, 26 mg / L, and 28 mg / L can also be selected.
在一些实施方式中,所述蛋白成分包括牛血清白蛋白10.0-20.0mg/L、转铁蛋白2.5-5.5mg/L以及胰岛素5.0-12.0mg/L;In some embodiments, the protein component includes bovine serum albumin 10.0-20.0 mg / L, transferrin 2.5-5.5 mg / L, and insulin 5.0-12.0 mg / L;
在一些实施方式中,所述蛋白成分包括牛血清白蛋白13.0-17.0mg/L、转铁蛋白4.5-5.5mg/L以及胰岛素9.0-11.0mg/L;In some embodiments, the protein component includes bovine serum albumin 13.0-17.0 mg / L, transferrin 4.5-5.5 mg / L, and insulin 9.0-11.0 mg / L;
在一些实施方式中,所述基础生理缓冲剂混合物以DMEM/F12为基础培养基,并加入包括氨基酸、维生素、无机盐、微量元素、脂类中的一种或多种;In some embodiments, the basic physiological buffer mixture is based on DMEM / F12 as a basic medium, and one or more of amino acids, vitamins, inorganic salts, trace elements, and lipids are added;
在一些实施方式中,所述DMEM/F12中DMEM与F12的体积比值为0.8-1.2;In some embodiments, the volume ratio of DMEM to F12 in DMEM / F12 is 0.8-1.2;
所述DMEM/F12中DMEM与F12的体积比值为1。The volume ratio of DMEM to F12 in the DMEM / F12 is 1.
在一些实施方式中,所述脂类由以下各者所构成的群组中选出:In some embodiments, the lipid is selected from the group consisting of:
花生四烯酸10-50μg/L、胆固醇1500-3500μg/L、亚油酸50-250μg/L、亚麻酸50-250μg/L、油酸50-250μg/L、棕榈烯酸50-250μg/L、硬脂酸50-250μg/L、乙醇胺1500-3500μg/L。Arachidonic acid 10-50μg / L, cholesterol 1500-3500μg / L, linoleic acid 50-250μg / L, linolenic acid 50-250μg / L, oleic acid 50-250μg / L, palmitoleic acid 50-250μg / L , Stearic acid 50-250μg / L, ethanolamine 1500-3500μg / L.
在一些实施方式中,所述脂类由以下各者所构成的群组中选出:In some embodiments, the lipid is selected from the group consisting of:
花生四烯酸10-40μg/L、胆固醇2500-3500μg/L、亚油酸130-230μg/L、亚麻酸150-250μg/L、油酸130-230μg/L、棕榈烯酸75-175μg/L、硬脂酸50-150μg/L、乙醇胺2200-3200μg/L。Arachidonic acid 10-40μg / L, cholesterol 2500-3500μg / L, linoleic acid 130-230μg / L, linolenic acid 150-250μg / L, oleic acid 130-230μg / L, palmitoleic acid 75-175μg / L , Stearic acid 50-150μg / L, ethanolamine 2200-3200μg / L.
在一些实施方式中,所述脂类由以下各者所构成的群组中选出:In some embodiments, the lipid is selected from the group consisting of:
花生四烯酸20-30μg/L、胆固醇2800-3200μg/L、亚油酸160-200μg/L、亚麻酸180-210μg/L、油酸170-190μg/L、棕榈烯酸115-135μg/L、硬脂酸80-120μg/L、乙醇胺2500-2900μg/L。Arachidonic acid 20-30μg / L, cholesterol 2800-3200μg / L, linoleic acid 160-200μg / L, linolenic acid 180-210μg / L, oleic acid 170-190μg / L, palmitoleic acid 115-135μg / L , Stearic acid 80-120μg / L, ethanolamine 2500-2900μg / L.
在一些实施方式中,所述氨基酸由以下各者所构成的群组中选出:In some embodiments, the amino acid is selected from the group consisting of:
精氨酸36-58mg/L、胱氨酸8-12mg/L、组氨酸9-15mg/L、异亮氨酸13-23mg/L、 亮氨酸13-23mg/L、赖氨酸14-22mg/L、甲硫氨酸4-7mg/L、苯丙氨酸9-15mg/L、苏氨酸18-22mg/L、色氨酸3-5mg/L、酪氨酸9-16mg/L、缬氨酸18-22mg/L、甘氨酸4-7mg/L、丙氨酸5-9mg/L、天冬酰胺8-12mg/L、天冬氨酸8-12mg/L、谷氨酸8-12mg/L、脯氨酸5-9mg/L、丝氨酸5-9mg/L。Arginine 36-58mg / L, cystine 8-12mg / L, histidine 9-15mg / L, isoleucine 13-23mg / L, leucine 13-23mg / L, lysine 14 -22mg / L, methionine 4-7mg / L, phenylalanine 9-15mg / L, threonine 18-22mg / L, tryptophan 3-5mg / L, tyrosine 9-16mg / L, Valine 18-22mg / L, Glycine 4-7mg / L, Alanine 5-9mg / L, Asparagine 8-12mg / L, Aspartic acid 8-12mg / L, Glutamate 8 -12mg / L, proline 5-9mg / L, serine 5-9mg / L.
在一些实施方式中,所述氨基酸由以下各者所构成的群组中选出:In some embodiments, the amino acid is selected from the group consisting of:
精氨酸40-54mg/L、胱氨酸9-11mg/L、组氨酸11-14mg/L、异亮氨酸16-20mg/L、亮氨酸16-20mg/L、赖氨酸16-20mg/L、甲硫氨酸5-6mg/L、苯丙氨酸11-13mg/L、苏氨酸19-21mg/L、色氨酸3-5mg/L、酪氨酸11-14mg/L、缬氨酸19-21mg/L、甘氨酸5-6mg/L、丙氨酸6-8mg/L、天冬酰胺9-11mg/L、天冬氨酸9-11mg/L、谷氨酸9-11mg/L、脯氨酸6-8mg/L、丝氨酸6-8mg/L。Arginine 40-54mg / L, cystine 9-11mg / L, histidine 11-14mg / L, isoleucine 16-20mg / L, leucine 16-20mg / L, lysine 16 -20mg / L, methionine 5-6mg / L, phenylalanine 11-13mg / L, threonine 19-21mg / L, tryptophan 3-5mg / L, tyrosine 11-14mg / L, Valine 19-21mg / L, Glycine 5-6mg / L, Alanine 6-8mg / L, Asparagine 9-11mg / L, Aspartic acid 9-11mg / L, Glutamate 9 -11mg / L, proline 6-8mg / L, serine 6-8mg / L.
在一些实施方式中,所述维生素中由以下各者所构成的群组中选出:In some embodiments, the vitamin is selected from the group consisting of:
氯化胆碱、泛酸钙、叶酸、尼克酰胺、盐酸吡哆醛、核黄素、硫胺素、肌醇;Choline chloride, calcium pantothenate, folic acid, nicotinamide, pyridoxal hydrochloride, riboflavin, thiamine, inositol;
在一些实施方式中,上述维生素的浓度可以选自0.7-1.8mg/L,还可以选择0.8mg/L、0.9mg/L、1.0mg/L、1.1mg/L、1.2mg/L、1.3mg/L、1.4mg/L、1.5mg/L、1.6mg/L、1.7mg/L;各维生素的浓度可以相同或不同。In some embodiments, the concentration of the above vitamins may be selected from 0.7-1.8 mg / L, and may also be selected from 0.8 mg / L, 0.9 mg / L, 1.0 mg / L, 1.1 mg / L, 1.2 mg / L, 1.3 mg / L, 1.4mg / L, 1.5mg / L, 1.6mg / L, 1.7mg / L; the concentration of each vitamin can be the same or different.
在一些实施方式中,所述维生素由以下各者所构成的群组中选出:In some embodiments, the vitamin is selected from the group consisting of:
氯化胆碱0.7-1.8mg/L、泛酸钙0.7-1.8mg/L、叶酸0.7-1.8mg/L、尼克酰胺0.7-1.8mg/L、盐酸吡哆醛0.7-1.8mg/L、核黄素0.7-1.8mg/L、硫胺素0.7-1.8mg/L、肌醇0.7-1.8mg/L。Choline chloride 0.7-1.8mg / L, calcium pantothenate 0.7-1.8mg / L, folic acid 0.7-1.8mg / L, nicotinamide 0.7-1.8mg / L, pyridoxal hydrochloride 0.7-1.8mg / L, nuclear yellow It is 0.7-1.8mg / L, thiamine 0.7-1.8mg / L and inositol 0.7-1.8mg / L.
在一些实施方式中,所述维生素由以下各者所构成的群组中选出:In some embodiments, the vitamin is selected from the group consisting of:
氯化胆碱1.0-1.4mg/L、泛酸钙0.8-1.4mg/L、叶酸1.0-1.4mg/L、尼克酰胺1.0-1.4mg/L、盐酸吡哆醛1.0-1.4mg/L、核黄素1.0-1.4mg/L、硫胺素1.0-1.4mg/L、肌醇1.0-1.4mg/L。Choline chloride 1.0-1.4mg / L, calcium pantothenate 0.8-1.4mg / L, folic acid 1.0-1.4mg / L, nicotinamide 1.0-1.4mg / L, pyridoxal hydrochloride 1.0-1.4mg / L, nuclear yellow 1.0-1.4mg / L, thiamine 1.0-1.4mg / L, inositol 1.0-1.4mg / L.
在一些实施方式中,所述无机盐由以下各者所构成的群组中选出:In some embodiments, the inorganic salt is selected from the group consisting of:
柠檬酸铁5-15mg/L、丙酮酸钠40-60mg/L、氯化钙1-5mg/L、硫酸镁1-5mg/L、氯化钾4-10mg/L、氯化钠80-100mg/L、磷酸二氢钠100-200mg/L。Ferric citrate 5-15mg / L, sodium pyruvate 40-60mg / L, calcium chloride 1-5mg / L, magnesium sulfate 1-5mg / L, potassium chloride 4-10mg / L, sodium chloride 80-100mg / L, sodium dihydrogen phosphate 100-200mg / L.
在一些实施方式中,所述无机盐由以下各者所构成的群组中选出:In some embodiments, the inorganic salt is selected from the group consisting of:
柠檬酸铁8-12mg/L、丙酮酸钠45-55mg/L、氯化钙2-4mg/L、硫酸镁2-4mg/L、 氯化钾6-8mg/L、氯化钠85-100mg/L、磷酸二氢钠100-140mg/L。Ferric citrate 8-12mg / L, sodium pyruvate 45-55mg / L, calcium chloride 2-4mg / L, magnesium sulfate 2-4mg / L, potassium chloride 6-8mg / L, sodium chloride 85-100mg / L, sodium dihydrogen phosphate 100-140mg / L.
在一些实施方式中,所述培养基包含一或多种由以下各者所构成的群组中选出的微量元素:In some embodiments, the culture medium contains one or more trace elements selected from the group consisting of:
硒、钼酸盐、铬、钴、镍、锌、铜、锰、钡、镓、锂、锡、钛、溴、碘、钒、锗、钼、硅、铁、氟、银、铷、锆、镉以及铝;Selenium, molybdate, chromium, cobalt, nickel, zinc, copper, manganese, barium, gallium, lithium, tin, titanium, bromine, iodine, vanadium, germanium, molybdenum, silicon, iron, fluorine, silver, rubidium, zirconium, Cadmium and aluminum;
在一些实施方式中,所述微量元素为硒,以亚硒酸的形式添加,含量为3-8μg/L。In some embodiments, the trace element is selenium, added in the form of selenite, and the content is 3-8 μg / L.
在一些实施方式中,所述基础生理缓冲剂混合物还包括缓冲液和/或抗剪切力保护剂;In some embodiments, the basic physiological buffer mixture further includes a buffer and / or an anti-shear protection agent;
在一些实施方式中,所述缓冲液为碳酸氢钠1.0-1.8g/L和Hepes3.2-4.5mg/L;In some embodiments, the buffer is sodium bicarbonate 1.0-1.8g / L and Hepes3.2-4.5mg / L;
在一些实施方式中,所述的抗剪切力保护剂为Pluronic F-68700-2000mg/L。In some embodiments, the anti-shear protection agent is Pluronic F-68700-2000 mg / L.
根据本申请的一方面,本申请还涉及一种培养细胞的方法,包括:在如上所述的培养基中培养细胞;According to an aspect of the present application, the present application also relates to a method of culturing cells, comprising: culturing the cells in the medium as described above;
在一些实施方式中,所述细胞为多能干细胞、胚胎干细胞、骨髓基质细胞、造血祖细胞、淋巴干细胞、骨髓干细胞、T细胞、B细胞、巨噬细胞、肝细胞、胰腺细胞、癌瘤细胞以及细胞系;In some embodiments, the cells are pluripotent stem cells, embryonic stem cells, bone marrow stromal cells, hematopoietic progenitor cells, lymphatic stem cells, bone marrow stem cells, T cells, B cells, macrophages, liver cells, pancreatic cells, cancer cells And cell lines;
在一些实施方式中,其中所述细胞系是由以下各者所构成的群组中选出:In some embodiments, wherein the cell line is selected from the group consisting of:
CHO、CHOK1、DXB-11、DG-44、CHO/-DHFR、CV1、COS-7、HEK293、BHK、TM4、VERO、HELA、MDCK、BRL3A、W138、Hep G2、SK-Hep、MMT、TRI、MRC5、FS4、T细胞系、B细胞系、3T3、RIN、A549、PC12、K562、PER.C6、SP2/0、NS-0、U20S、HT1080、L929、融合瘤以及癌细胞系。CHO, CHOK1, DXB-11, DG-44, CHO / -DHFR, CV1, COS-7, HEK293, BHK, TM4, VERO, HELA, MDCK, BRL3A, W138, Hep G2, SK-Hep, MMT, TRI, MRC5, FS4, T cell line, B cell line, 3T3, RIN, A549, PC12, K562, PER.C6, SP2 / 0, NS-0, U20S, HT1080, L929, fusion tumor and cancer cell lines.
在一个具体的实施方式中,所述细胞为杂交瘤细胞。杂交瘤细胞是一种能分泌单一独特抗体的无限传代细胞,其分泌的单克隆抗体在疫苗生产、体外诊断和生物医药方面有着广泛的应用。该培养基能使杂交瘤细胞在悬浮条件下正常生长并表达单克隆抗体,一方面满足体外诊断试剂行业对单抗的需求,另一方面可以降低成本。In a specific embodiment, the cell is a hybridoma cell. A hybridoma cell is an infinitely passaged cell capable of secreting a single unique antibody. The monoclonal antibody secreted by it is widely used in vaccine production, in vitro diagnosis, and biomedicine. The medium enables hybridoma cells to grow normally and express monoclonal antibodies under suspension conditions. On the one hand, it meets the needs of monoclonal antibodies in the in vitro diagnostic reagent industry, and on the other hand, it can reduce costs.
下面将结合实施例对本申请的实施方案进行详细描述,但是本领域技术人员将会理解,下列实施例仅用于说明本申请,而不应视为限制本申请的范围。实施例中未注明具体条件者,按照常规条件或制造商建议的条件进行。所用试剂或仪器未注明生产厂商者,均为可以通过市购获得的常规产品。The embodiments of the present application will be described in detail below in conjunction with examples, but those skilled in the art will understand that the following examples are only used to illustrate the present application and should not be considered as limiting the scope of the present application. If no specific conditions are indicated in the examples, the conventional conditions or the conditions recommended by the manufacturer shall be followed. The reagents or instruments used do not indicate the manufacturer, are all conventional products that are commercially available.
实施例1Example 1
无血清培养基成分筛选和优化。Screening and optimization of serum-free medium components.
以六孔板,3mL培养体系,培养杂交瘤细胞株1D7,在培养72h时取样计培养体系中活细胞密度。利用L16(45)正交试验方法,查阅相关文献资料经过筛选后确定5类对细胞培养起促进作用的添加剂,5类对细胞培养起促进作用的添加剂分别是:A,8种脂类;B,8种维生素;C,3种蛋白;D,19种氨基酸;E,7种无机盐。Using a 6-well plate and a 3 mL culture system, the hybridoma cell line 1D7 was cultured, and the viable cell density in the culture system was sampled at 72 hours. Using the L16 (45) orthogonal test method, referring to relevant literature materials, after screening, 5 types of additives that promote cell culture were determined. The 5 types of additives that promote cell culture were: A, 8 types of lipids; B , 8 vitamins; C, 3 proteins; D, 19 amino acids; E, 7 inorganic salts.
试验以DMEM/F12(v/v,1:1)为基础培养基,预先加入亚硒酸6μg/L、碳酸氢钠1.5g/L和Hepes3.8mg/L、Pluronic F-681300mg/L。采用正交试验方法对所选五种添加剂进行优化,每个因素(A,B,C,D,E)设置四个不同浓度水平(1,2,3,4,所含添加物浓度从低到高)。The test was based on DMEM / F12 (v / v, 1: 1), and pre-added 6μg / L selenite, 1.5g / L sodium bicarbonate and 3.8mg / L Hepes, and Pluronic F-681300mg / L. Orthogonal test method is used to optimize the five selected additives, each factor (A, B, C, D, E) is set to four different concentration levels (1,2,3,4, the concentration of additives contained from low To high).
A1中花生四烯酸10μg/L、胆固醇500μg/L、亚油酸80μg/L、亚麻酸80μg/L、油酸80μg/L、棕榈烯酸50μg/L、硬脂酸50μg/L、乙醇胺1000μg/L。In A1, arachidonic acid 10 μg / L, cholesterol 500 μg / L, linoleic acid 80 μg / L, linolenic acid 80 μg / L, oleic acid 80 μg / L, palmitoleic acid 50 μg / L, stearic acid 50 μg / L, ethanolamine 1000 μg / L.
A2中花生四烯酸15μg/L、胆固醇1000μg/L、亚油酸100μg/L、亚麻酸120μg/L、油酸120μg/L、棕榈烯酸80μg/L、硬脂酸60μg/L、乙醇胺1500μg/L。In A2, arachidonic acid 15μg / L, cholesterol 1000μg / L, linoleic acid 100μg / L, linolenic acid 120μg / L, oleic acid 120μg / L, palmitoleic acid 80μg / L, stearic acid 60μg / L, ethanolamine 1500μg / L.
A3中花生四烯酸20μg/L、胆固醇2000μg/L、亚油酸150μg/L、亚麻酸160μg/L、油酸160μg/L、棕榈烯酸100μg/L、硬脂酸80μg/L、乙醇胺2000μg/L。A3 arachidonic acid 20μg / L, cholesterol 2000μg / L, linoleic acid 150μg / L, linolenic acid 160μg / L, oleic acid 160μg / L, palmitoleic acid 100μg / L, stearic acid 80μg / L, ethanolamine 2000μg / L.
A4中花生四烯酸25μg/L、胆固醇3000μg/L、亚油酸180μg/L、亚麻酸200μg/L、油酸180μg/L、棕榈烯酸125μg/L、硬脂酸100μg/L、乙醇胺2700μg/L。In A4, arachidonic acid 25μg / L, cholesterol 3000μg / L, linoleic acid 180μg / L, linolenic acid 200μg / L, oleic acid 180μg / L, palmitoyl acid 125μg / L, stearic acid 100μg / L, ethanolamine 2700μg / L.
B1中氯化胆碱0.2mg/L、泛酸钙0.2mg/L、叶酸0.2mg/L、尼克酰胺0.2mg/L、盐酸吡哆醛0.2mg/L、核黄素0.2mg/L、硫胺素0.2mg/L、肌醇0.2mg/LB1 choline chloride 0.2mg / L, calcium pantothenate 0.2mg / L, folic acid 0.2mg / L, nicotinamide 0.2mg / L, pyridoxal hydrochloride 0.2mg / L, riboflavin 0.2mg / L, thiamine 0.2mg / L, inositol 0.2mg / L
B2中氯化胆碱0.4mg/L、泛酸钙0.4mg/L、叶酸0.4mg/L、尼克酰胺0.4mg/L、盐酸吡哆醛0.4mg/L、核黄素0.4mg/L、硫胺素0.4mg/L、肌醇0.4mg/LB2 Choline Chloride 0.4mg / L, Calcium Pantothenate 0.4mg / L, Folic Acid 0.4mg / L, Nicotinamide 0.4mg / L, Pyridoxal Hydrochloride 0.4mg / L, Riboflavin 0.4mg / L, Thiamine 0.4mg / L, Inositol 0.4mg / L
B3中氯化胆碱0.8mg/L、泛酸钙0.8mg/L、叶酸0.8mg/L、尼克酰胺0.8mg/L、盐酸吡哆醛0.8mg/L、核黄素0.8mg/L、硫胺素0.8mg/L、肌醇0.8mg/LB3 choline chloride 0.8mg / L, calcium pantothenate 0.8mg / L, folic acid 0.8mg / L, nicotinamide 0.8mg / L, pyridoxal hydrochloride 0.8mg / L, riboflavin 0.8mg / L, thiamine Element 0.8mg / L, inositol 0.8mg / L
B4中氯化胆碱1.2mg/L、泛酸钙1.2mg/L、叶酸1.2mg/L、尼克酰胺1.2mg/L、盐酸吡哆醛1.2mg/L、核黄素1.2mg/L、硫胺素1.2mg/L、肌醇1.2mg/LB4 choline chloride 1.2mg / L, calcium pantothenate 1.2mg / L, folic acid 1.2mg / L, nicotinamide 1.2mg / L, pyridoxal hydrochloride 1.2mg / L, riboflavin 1.2mg / L, thiamine 1.2mg / L, Inositol 1.2mg / L
C1中BSA为5mg/L,转铁蛋白为2mg/L,胰岛素为3mg/L;In C1, BSA is 5 mg / L, transferrin is 2 mg / L, and insulin is 3 mg / L;
C2中BSA为10mg/L,转铁蛋白为2mg/L,胰岛素为5mg/L;In C2, BSA is 10 mg / L, transferrin is 2 mg / L, and insulin is 5 mg / L;
C3中BSA为15mg/L,转铁蛋白为5mg/L,胰岛素为8mg/L;In C3, BSA is 15 mg / L, transferrin is 5 mg / L, and insulin is 8 mg / L;
C4中BSA为15mg/L,转铁蛋白为5mg/L,胰岛素为10mg/L。In C4, BSA is 15 mg / L, transferrin is 5 mg / L, and insulin is 10 mg / L.
D1中精氨酸24mg/L、胱氨酸5mg/L、组氨酸6mg/L、异亮氨酸9.5mg/L、亮氨酸9mg/L、赖氨酸9mg/L、甲硫氨酸3.5mg/L、苯丙氨酸5.5mg/L、苏氨酸9.5mg/L、色氨酸2mg/L、酪氨酸7mg/L、缬氨酸10mg/L、甘氨酸2.5mg/L、丙氨酸3.5mg/L、天冬酰胺5mg/L、天冬氨酸5mg/L、谷氨酸5mg/L、脯氨酸3mg/L、丝氨酸3mg/LD1 arginine 24mg / L, cystine 5mg / L, histidine 6mg / L, isoleucine 9.5mg / L, leucine 9mg / L, lysine 9mg / L, methionine 3.5mg / L, Phenylalanine 5.5mg / L, Threonine 9.5mg / L, Tryptophan 2mg / L, Tyrosine 7mg / L, Valine 10mg / L, Glycine 2.5mg / L, Alanine 3.5mg / L of aspartic acid, 5mg / L of asparagine, 5mg / L of aspartic acid, 5mg / L of glutamic acid, 3mg / L of proline, 3mg / L of serine
D2中精氨酸48mg/L、胱氨酸10mg/L、组氨酸12mg/L、异亮氨酸19mg/L、亮氨酸18mg/L、赖氨酸18mg/L、甲硫氨酸7mg/L、苯丙氨酸11mg/L、苏氨酸19mg/L、色氨酸4mg/L、酪氨酸14mg/L、缬氨酸20mg/L、甘氨酸5mg/L、丙氨酸7mg/L、天冬酰胺10mg/L、天冬氨酸10mg/L、谷氨酸10mg/L、脯氨酸6mg/L、丝氨酸6mg/LD2 arginine 48mg / L, cystine 10mg / L, histidine 12mg / L, isoleucine 19mg / L, leucine 18mg / L, lysine 18mg / L, methionine 7mg / L, phenylalanine 11mg / L, threonine 19mg / L, tryptophan 4mg / L, tyrosine 14mg / L, valine 20mg / L, glycine 5mg / L, alanine 7mg / L , Asparagine 10mg / L, aspartic acid 10mg / L, glutamic acid 10mg / L, proline 6mg / L, serine 6mg / L
D3中精氨酸96mg/L、胱氨酸20mg/L、组氨酸24mg/L、异亮氨酸38mg/L、亮氨酸36mg/L、赖氨酸36mg/L、甲硫氨酸14mg/L、苯丙氨酸22mg/L、苏氨酸38mg/L、色氨酸8mg/L、酪氨酸28mg/L、缬氨酸40mg/L、甘氨酸10mg/L、丙氨酸14mg/L、天冬酰胺20mg/L、天冬氨酸20mg/L、谷氨酸20mg/L、脯氨酸12mg/L、丝氨酸12mg/LD3 arginine 96mg / L, cystine 20mg / L, histidine 24mg / L, isoleucine 38mg / L, leucine 36mg / L, lysine 36mg / L, methionine 14mg / L, phenylalanine 22mg / L, threonine 38mg / L, tryptophan 8mg / L, tyrosine 28mg / L, valine 40mg / L, glycine 10mg / L, alanine 14mg / L , Asparagine 20mg / L, aspartic acid 20mg / L, glutamic acid 20mg / L, proline 12mg / L, serine 12mg / L
D4中精氨酸192mg/L、胱氨酸40mg/L、组氨酸48mg/L、异亮氨酸76mg/L、亮氨酸72mg/L、赖氨酸72mg/L、甲硫氨酸28mg/L、苯丙氨酸44mg/L、苏氨酸76mg/L、色氨酸16mg/L、酪氨酸56mg/L、缬氨酸80mg/L、甘氨酸20mg/L、丙氨酸28mg/L、天冬酰胺40mg/L、天冬氨酸40mg/L、谷氨酸40mg/L、脯氨酸24mg/L、丝氨酸24mg/LD4 arginine 192mg / L, cystine 40mg / L, histidine 48mg / L, isoleucine 76mg / L, leucine 72mg / L, lysine 72mg / L, methionine 28mg / L, phenylalanine 44mg / L, threonine 76mg / L, tryptophan 16mg / L, tyrosine 56mg / L, valine 80mg / L, glycine 20mg / L, alanine 28mg / L , Asparagine 40mg / L, aspartic acid 40mg / L, glutamic acid 40mg / L, proline 24mg / L, serine 24mg / L
E1中柠檬酸铁12mg/L、丙酮酸钠50mg/L、氯化钙4mg/L、硫酸镁3mg/L、氯化钾7mg/L、氯化钠100mg/L、磷酸二氢钠120mg/LE1 iron citrate 12mg / L, sodium pyruvate 50mg / L, calcium chloride 4mg / L, magnesium sulfate 3mg / L, potassium chloride 7mg / L, sodium chloride 100mg / L, sodium dihydrogen phosphate 120mg / L
E2中柠檬酸铁18mg/L、丙酮酸钠75mg/L、氯化钙6mg/L、硫酸镁4.5mg/L、氯化钾7mg/L、氯化钠150mg/L、磷酸二氢钠150mg/LIn E2, iron citrate 18mg / L, sodium pyruvate 75mg / L, calcium chloride 6mg / L, magnesium sulfate 4.5mg / L, potassium chloride 7mg / L, sodium chloride 150mg / L, sodium dihydrogen phosphate 150mg / L
E3中柠檬酸铁27mg/L、丙酮酸钠112.5mg/L、氯化钙9mg/L、硫酸镁6.75mg/L、氯化钾7mg/L、氯化钠200mg/L、磷酸二氢钠200mg/LE3 iron citrate 27mg / L, sodium pyruvate 112.5mg / L, calcium chloride 9mg / L, magnesium sulfate 6.75mg / L, potassium chloride 7mg / L, sodium chloride 200mg / L, sodium dihydrogen phosphate 200mg / L
E4中柠檬酸铁40.5mg/L、丙酮酸钠168.75mg/L、氯化钙13.5mg/L、硫酸镁10 mg/L、氯化钾7mg/L、氯化钠250mg/L、磷酸二氢钠250mg/LIn E4, iron citrate 40.5mg / L, sodium pyruvate 168.75mg / L, calcium chloride 13.5mg / L, magnesium sulfate 10mg / L, potassium chloride 7mg / L, sodium chloride 250mg / L, dihydrogen phosphate Sodium 250mg / L
结果如表1所示。The results are shown in Table 1.
表1正交试验优化Table 1 Orthogonal test optimization
Figure PCTCN2019091341-appb-000001
Figure PCTCN2019091341-appb-000001
对培养至72h时培养体系中活细胞密度的平均值进行比较,正交试验结果表明,16组不同组合添加因子中,A4B4C4D2E1组合对活细胞密度促进最大。根据极差R大小判断各因素对活细胞密度影响大小,得出各因素影响主次顺序为C>A>D>B>E。在此基础上确定这5中不同添加因子最优水平为:A4B4C4D2E1。以最优水平组合的添加剂浓度进行作为培养基的优选浓度,后续进行实施例2的细胞培养。Comparing the average value of the density of living cells in the culture system at 72 hours of culture, the results of orthogonal test showed that among the 16 groups of different combinations of added factors, the combination of A4B4C4D2E1 promoted the density of living cells the most. According to the size of the range R, the influence of each factor on the density of living cells was determined, and the order of the influence of each factor was C> A> D> B> E. On this basis, the optimal level of the five different additive factors is determined as: A4B4C4D2E1. The concentration of the additive combined at the optimal level was performed as the preferred concentration of the culture medium, followed by the cell culture of Example 2.
实施例2Example 2
无血清培养基制备和细胞培养Serum-free medium preparation and cell culture
1.培养基制备1. Medium Preparation
在以DMEM/F12(v/v,1:1)为基础培养基中添加以下物质:Add the following substances to DMEM / F12 (v / v, 1: 1) as the basic medium:
牛血清白蛋白15.0mg/L、转铁蛋白5mg/L、胰岛素10mg/L、精氨酸48mg/L、胱氨酸10mg/L、组氨酸12mg/L、异亮氨酸19mg/L、亮氨酸18mg/L、赖氨酸18mg/L、甲硫氨酸7mg/L、苯丙氨酸11mg/L、苏氨酸19mg/L、色氨酸4mg/L、酪氨酸14mg/L、缬氨酸20mg/L、甘氨酸5mg/L、丙氨酸7mg/L、天冬酰胺10mg/L、天冬氨酸10mg/L、谷氨酸10mg/L、脯氨酸6mg/L、丝氨酸6mg/L、氯化胆碱1.2mg/L、泛酸钙1.2mg/L、叶酸1.2mg/L、尼克酰胺1.2mg/L、盐酸吡哆醛1.2mg/L、核黄素1.2mg/L、硫胺素1.2mg/L、肌醇1.2mg/L、柠檬酸铁12mg/L、丙酮酸钠50mg/L、氯化钙4mg/L、硫酸镁3mg/L、氯化钾7mg/L、氯化钠100mg/L、磷酸二氢钠120mg/L、花生四烯酸25μg/L、胆固醇3000μg/L、亚油酸180μg/L、亚麻酸200μg/L、油酸180μg/L、棕榈烯酸125μg/L、硬脂酸100μg/L、乙醇胺2700μg/L、亚硒酸6μg/L、碳酸氢钠1.5g/L和Hepes3.8mg/L、Pluronic F-681300mg/L。培养基按照常规方法配制后用0.22μm微孔滤器过滤除菌。Bovine serum albumin 15.0mg / L, transferrin 5mg / L, insulin 10mg / L, arginine 48mg / L, cystine 10mg / L, histidine 12mg / L, isoleucine 19mg / L, Leucine 18mg / L, Lysine 18mg / L, Methionine 7mg / L, Phenylalanine 11mg / L, Threonine 19mg / L, Tryptophan 4mg / L, Tyrosine 14mg / L , Valine 20mg / L, glycine 5mg / L, alanine 7mg / L, asparagine 10mg / L, aspartic acid 10mg / L, glutamic acid 10mg / L, proline 6mg / L, serine 6mg / L, choline chloride 1.2mg / L, calcium pantothenate 1.2mg / L, folic acid 1.2mg / L, nicotinamide 1.2mg / L, pyridoxal hydrochloride 1.2mg / L, riboflavin 1.2mg / L, Thiamin 1.2mg / L, inositol 1.2mg / L, iron citrate 12mg / L, sodium pyruvate 50mg / L, calcium chloride 4mg / L, magnesium sulfate 3mg / L, potassium chloride 7mg / L, chlorine Sodium chloride 100mg / L, sodium dihydrogen phosphate 120mg / L, arachidonic acid 25μg / L, cholesterol 3000μg / L, linoleic acid 180μg / L, linolenic acid 200μg / L, oleic acid 180μg / L, palmitic acid 125μg / L, stearic acid 100μg / L, ethanolamine 2700μg / L, selenite 6μg / L, sodium bicarbonate 1.5g / L and Hepes 3.8mg / L, Pluronic F-681300mg / L. After the medium is prepared according to the conventional method, it is sterilized by filtering with a 0.22 μm microporous filter.
2.细胞培养2. Cell culture
液氮灌中取出冻存的杂交瘤细胞株1C3细胞,迅速置于37℃水浴槽中,待完全溶化后离心去上清,用少量上述无血清培养基轻轻吹打细胞,使细胞混合均匀然后转移至方瓶中,然后置于37℃、5%CO2湿度饱和的CO2培养箱中传代培养。Remove the frozen hybridoma cell line 1C3 cells from the liquid nitrogen irrigation, and quickly place them in a 37 ° C water bath. After complete thawing, centrifuge to remove the supernatant. Gently pipette the cells with a small amount of the above serum-free medium to mix the cells. Transfer to a square bottle, and then subculture in a CO2 incubator at 37 ° C and 5% CO2 humidity saturation.
3.与GIBCO品牌无血清培养基Hybridoma-SFM比较3. Compared with GIBCO brand serum-free medium Hybridoma-SFM
将上述1C3细胞进行扩大培养并传入4个方瓶中,待生长至细胞对数期时一起接种至1.5L转瓶,以初始培养密度约为70×104cells/ml,然后置于37℃、5%CO2湿度饱和培养箱悬浮培养。The above 1C3 cells were expanded and introduced into 4 square flasks. When they were grown to the logarithmic phase, they were inoculated into 1.5L spinner flasks at an initial culture density of about 70 × 104cells / ml, and then placed at 37 ℃, 5% CO2 humidity saturated incubator suspension culture.
如图1所示,处于下方的曲线为本申请所述无血清培养基培养的杂交瘤细胞的生长曲线,处于上方的曲线为GIBCO Hybridoma-SFM培养基培养的杂交瘤细胞生长曲线。整个培养过程持续8天。本申请无血清培养基与GIBCO Hybridoma-SFM培养基活细胞密度在120h分别达到537×104cells/ml和551×104cells/ml,本申请所述无血清培养基的培养效果几乎等同于国外厂家生产的同类培养基的培养效果,同时本申请无血清培养基成本相对低廉,且化学成分明确,蛋白含量极低。As shown in FIG. 1, the lower curve is the growth curve of the hybridoma cells cultured in the serum-free medium described in this application, and the upper curve is the growth curve of the hybridoma cells cultured in GIBCO Hybridoma-SFM medium. The whole cultivation process lasts 8 days. Serum-free medium and GIBCO Hybridoma-SFM medium live cell density of this application reached 537 × 104cells / ml and 551 × 104cells / ml respectively at 120h. The culture effect of the serum-free medium described in this application is almost equal to that produced by foreign manufacturers The cultivation effect of the same culture medium, meanwhile, the serum-free culture medium of the present application has relatively low cost, clear chemical composition, and extremely low protein content.
实施例3Example 3
补料批式培养杂交瘤细胞株制备单克隆抗体Fed-batch culture of hybridoma cell lines to prepare monoclonal antibodies
将本申请所述无血清培养基用于杂交瘤细胞株DF92、1A4进行发酵罐悬浮培养,培养基配方同实施例2中相同。DF92使用广州齐志生物公司14L生物反应器,初始培养体积为2L,控制条件为:Temp 37±0.5℃,DO 50%±5%,pH 6.9±0.1,Stir speed 80rpm,1A4使用Applikon 2L生物反应器,初始培养体积为2L,控制条件为:Temp 37±0.5℃,DO 50%±5%,pH 6.9±0.1,Stir speed 80rpm,在悬浮培养过程中,采用的是补料批式培养方法,每间隔约24h取样监测相关数据,这些数据包括培养液中葡萄糖浓度、细胞密度、细胞活率和单抗表达量,两种细胞的培养结果如图2、4所示(图3为现有技术的培养基对照),按照培养基中葡萄糖消耗指标加入补料培养基,从开始补料起,补料间隔约为24h。当发酵罐内细胞活率降低至60%以下时,停止发酵罐的补料批式培养操作,离心收取上清后过滤,进行表达量测定和单克隆抗体的纯化。结果表明本申请所述无血清培养基能够正常用于杂交瘤细胞悬浮培养和单克隆抗体的制备,在相同培养条件下,细胞的生长状态和抗体产量与外购对照培养基相当或优于外购培养基,后续实验也证明使用该无血清培养基所制备的单抗可以正常用于体外诊断试剂领域。The serum-free medium described in the present application is used for the hybridoma cell lines DF92 and 1A4 for fermentor suspension culture, and the medium formula is the same as in Example 2. DF92 uses a 14L bioreactor of Guangzhou Qizhi Biological Company, the initial culture volume is 2L, the control conditions are: Temp 37 ± 0.5 ℃, DO 50% ± 5%, pH 6.9 ± 0.1, Stir speed 80rpm, 1A4 uses Applikon 2L biological reaction The initial culture volume is 2L, and the control conditions are: Temp 37 ± 0.5 ℃, DO 50% ± 5%, pH 6.9 ± 0.1, Stir speed 80rpm. In the suspension culture process, the fed-batch culture method is adopted. Sampling and monitoring the relevant data at intervals of about 24h. These data include glucose concentration, cell density, cell viability and monoclonal antibody expression in the culture medium. The culture results of the two cells are shown in Figures 2 and 4 (Figure 3 shows the prior art Medium control), add feed medium according to the glucose consumption index in the medium, and the feed interval is about 24h from the start of feed. When the cell viability in the fermentor drops below 60%, the fed batch culture operation of the fermentor is stopped, the supernatant is collected by centrifugation and filtered, and the expression level is determined and the monoclonal antibody is purified. The results show that the serum-free medium described in this application can be normally used for hybridoma cell suspension culture and the preparation of monoclonal antibodies. Under the same culture conditions, the cell growth status and antibody production are comparable to or better than those of the purchased control medium After purchasing the culture medium, subsequent experiments also proved that the monoclonal antibody prepared using the serum-free medium can be normally used in the field of in vitro diagnostic reagents.
最后应说明的是:以上各实施例仅用以说明本申请的技术方案,而非对其限制;尽管参照前述各实施例对本申请进行了详细的说明,但本领域的普通技术人员应当理解:其依然可以对前述各实施例所记载的技术方案进行修改,或者对其中部分或者全部技术特征进行等同替换;而这些修改或者替换,并不使相应技术方案的本质脱离本申请各实施例技术方案的范围。Finally, it should be noted that the above embodiments are only used to illustrate the technical solutions of the present application, not to limit them; although the present application has been described in detail with reference to the foregoing embodiments, those of ordinary skill in the art should understand: It can still modify the technical solutions described in the foregoing embodiments, or equivalently replace some or all of the technical features therein; and these modifications or replacements do not deviate from the essence of the corresponding technical solutions from the technical solutions of the embodiments of the present application Scope.

Claims (10)

  1. 一种低蛋白无血清细胞培养基,其特征在于,所述培养基包含基础生理缓冲剂混合物和蛋白成分;A low-protein serum-free cell culture medium, characterized in that the culture medium contains a basic physiological buffer mixture and protein components;
    所述蛋白成分包括牛血清白蛋白、转铁蛋白、胰岛素,且所述蛋白成分的总添加量不超过30mg/L。The protein component includes bovine serum albumin, transferrin, and insulin, and the total added amount of the protein component does not exceed 30 mg / L.
  2. 根据权利要求1所述的低蛋白无血清细胞培养基,其特征在于,所述蛋白成分包括牛血清白蛋白10.0-20.0mg/L、转铁蛋白2.5-5.5mg/L以及胰岛素5.0-12.0mg/L;The low-protein serum-free cell culture medium according to claim 1, wherein the protein component comprises bovine serum albumin 10.0-20.0 mg / L, transferrin 2.5-5.5 mg / L and insulin 5.0-12.0 mg / L;
    所述蛋白成分包括牛血清白蛋白13.0-17.0mg/L、转铁蛋白4.5-5.5mg/L以及胰岛素9.0-11.0mg/L。The protein components include bovine serum albumin 13.0-17.0 mg / L, transferrin 4.5-5.5 mg / L and insulin 9.0-11.0 mg / L.
  3. 根据权利要求1或2所述的低蛋白无血清细胞培养基,其特征在于,所述基础生理缓冲剂混合物以DMEM/F12为基础培养基,并加入包括氨基酸、维生素、无机盐、微量元素、脂类中的一种或多种;The low-protein serum-free cell culture medium according to claim 1 or 2, wherein the basic physiological buffer mixture uses DMEM / F12 as the basic medium, and includes amino acids, vitamins, inorganic salts, trace elements, One or more of lipids;
    所述DMEM/F12中DMEM与F12的体积比值为0.8-1.2;所述DMEM/F12中DMEM与F12的体积比值为1。The volume ratio of DMEM and F12 in the DMEM / F12 is 0.8-1.2; the volume ratio of DMEM and F12 in the DMEM / F12 is 1.
  4. 根据权利要求3所述的低蛋白无血清细胞培养基,其特征在于,所述脂类由以下各者所构成的群组中选出:The low-protein serum-free cell culture medium according to claim 3, wherein the lipid is selected from the group consisting of:
    花生四烯酸10-50μg/L、胆固醇1500-3500μg/L、亚油酸50-250μg/L、亚麻酸50-250μg/L、油酸50-250μg/L、棕榈烯酸50-250μg/L、硬脂酸50-250μg/L、乙醇胺1500-3500μg/L。Arachidonic acid 10-50μg / L, cholesterol 1500-3500μg / L, linoleic acid 50-250μg / L, linolenic acid 50-250μg / L, oleic acid 50-250μg / L, palmitoleic acid 50-250μg / L , Stearic acid 50-250μg / L, ethanolamine 1500-3500μg / L.
  5. 根据权利要求3所述的低蛋白无血清细胞培养基,其特征在于,所述氨基酸由以下各者所构成的群组中选出:The low-protein serum-free cell culture medium according to claim 3, wherein the amino acid is selected from the group consisting of:
    精氨酸36-58mg/L、胱氨酸8-12mg/L、组氨酸9-15mg/L、异亮氨酸13-23mg/L、亮氨酸13-23mg/L、赖氨酸14-22mg/L、甲硫氨酸4-7mg/L、苯丙氨酸9-15mg/L、苏氨酸18-22mg/L、色氨酸3-5mg/L、酪氨酸9-16mg/L、缬氨酸18-22mg/L、甘氨酸4-7mg/L、丙氨酸5-9mg/L、天冬酰胺8-12mg/L、天冬氨酸8-12mg/L、谷氨酸8-12mg/L、脯氨酸5-9mg/L、丝氨酸5-9mg/L。Arginine 36-58mg / L, cystine 8-12mg / L, histidine 9-15mg / L, isoleucine 13-23mg / L, leucine 13-23mg / L, lysine 14 -22mg / L, methionine 4-7mg / L, phenylalanine 9-15mg / L, threonine 18-22mg / L, tryptophan 3-5mg / L, tyrosine 9-16mg / L, Valine 18-22mg / L, Glycine 4-7mg / L, Alanine 5-9mg / L, Asparagine 8-12mg / L, Aspartic acid 8-12mg / L, Glutamate 8 -12mg / L, proline 5-9mg / L, serine 5-9mg / L.
  6. 根据权利要求3所述的低蛋白无血清细胞培养基,其特征在于,所述维生素由以下各者所构成的群组中选出:The low-protein serum-free cell culture medium according to claim 3, wherein the vitamin is selected from the group consisting of:
    氯化胆碱0.7-1.8mg/L、泛酸钙0.7-1.8mg/L、叶酸0.7-1.8mg/L、尼克酰胺0.7-1.8mg/L、盐酸吡哆醛0.7-1.8mg/L、核黄素0.7-1.8mg/L、硫胺素0.7-1.8mg/L、肌醇0.7-1.8mg/L。Choline chloride 0.7-1.8mg / L, calcium pantothenate 0.7-1.8mg / L, folic acid 0.7-1.8mg / L, nicotinamide 0.7-1.8mg / L, pyridoxal hydrochloride 0.7-1.8mg / L, nuclear yellow It is 0.7-1.8mg / L, thiamine 0.7-1.8mg / L and inositol 0.7-1.8mg / L.
  7. 根据权利要求3所述的低蛋白无血清细胞培养基,其特征在于,所述无机盐由以下各者所构成的群组中选出:The low-protein serum-free cell culture medium according to claim 3, wherein the inorganic salt is selected from the group consisting of:
    柠檬酸铁5-15mg/L、丙酮酸钠40-60mg/L、氯化钙1-5mg/L、硫酸镁1-5mg/L、氯化钾4-10mg/L、氯化钠80-100mg/L、磷酸二氢钠100-200mg/L。Ferric citrate 5-15mg / L, sodium pyruvate 40-60mg / L, calcium chloride 1-5mg / L, magnesium sulfate 1-5mg / L, potassium chloride 4-10mg / L, sodium chloride 80-100mg / L, sodium dihydrogen phosphate 100-200mg / L.
  8. 根据权利要求3所述的低蛋白无血清细胞培养基,其特征在于,所述培养基包含一或多种由以下各者所构成的群组中选出的微量元素:The low-protein serum-free cell culture medium according to claim 3, wherein the culture medium contains one or more trace elements selected from the group consisting of:
    硒、钼酸盐、铬、钴、镍、锌、铜、锰、钡、镓、锂、锡、钛、溴、碘、钒、锗、钼、硅、铁、氟、银、铷、锆、镉以及铝;Selenium, molybdate, chromium, cobalt, nickel, zinc, copper, manganese, barium, gallium, lithium, tin, titanium, bromine, iodine, vanadium, germanium, molybdenum, silicon, iron, fluorine, silver, rubidium, zirconium, Cadmium and aluminum;
    所述微量元素为硒,以亚硒酸的形式添加,含量为3-8μg/L。The trace element is selenium, added in the form of selenite, and the content is 3-8 μg / L.
  9. 根据权利要求3所述的低蛋白无血清细胞培养基,其特征在于,所述基础生理缓冲剂混合物还包括缓冲液和/或抗剪切力保护剂;The low-protein serum-free cell culture medium according to claim 3, wherein the basic physiological buffer mixture further comprises a buffer and / or an anti-shear protection agent;
    所述缓冲液为碳酸氢钠1.0-1.8g/L和Hepes3.2-4.5mg/L;The buffer solution is sodium bicarbonate 1.0-1.8g / L and Hepes 3.2-4.5mg / L;
    所述抗剪切力保护剂为Pluronic F-68700-2000mg/L。The anti-shear protection agent is Pluronic F-68700-2000mg / L.
  10. 一种培养细胞的方法,包括:在前述权利要求中任一项所述的低蛋白无血清细胞培养基中培养细胞;A method for culturing cells, comprising: culturing cells in the low-protein serum-free cell culture medium according to any one of the preceding claims;
    所述细胞为多能干细胞、胚胎干细胞、骨髓基质细胞、造血祖细胞、淋巴干细胞、骨髓干细胞、T细胞、B细胞、巨噬细胞、肝细胞、胰腺细胞、癌瘤细胞以及细胞系;The cells are pluripotent stem cells, embryonic stem cells, bone marrow stromal cells, hematopoietic progenitor cells, lymphatic stem cells, bone marrow stem cells, T cells, B cells, macrophages, liver cells, pancreatic cells, cancer cells, and cell lines;
    其中所述细胞系是由以下各者所构成的群组中选出:The cell line is selected from the group consisting of:
    CHO、CHOK1、DXB-11、DG-44、CHO/-DHFR、CV1、COS-7、HEK293、BHK、TM4、VERO、HELA、MDCK、BRL3A、W138、Hep G2、SK-Hep、MMT、TRI、MRC5、FS4、T细胞系、B细胞系、3T3、RIN、A549、PC12、K562、PER.C6、 SP2/0、NS-0、U20S、HT1080、L929、融合瘤以及癌细胞系。CHO, CHOK1, DXB-11, DG-44, CHO / -DHFR, CV1, COS-7, HEK293, BHK, TM4, VERO, HELA, MDCK, BRL3A, W138, Hep G2, SK-Hep, MMT, TRI, MRC5, FS4, T cell line, B cell line, 3T3, RIN, A549, PC12, K562, PER.C6, SP2 / 0, NS-0, U20S, HT1080, L929, fusion tumor and cancer cell lines.
PCT/CN2019/091341 2018-11-21 2019-06-14 Low-protein serum-free cell culture medium WO2020103439A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201811394132.1 2018-11-21
CN201811394132.1A CN109234223B (en) 2018-11-21 2018-11-21 Low-protein serum-free cell culture medium

Publications (1)

Publication Number Publication Date
WO2020103439A1 true WO2020103439A1 (en) 2020-05-28

Family

ID=65076258

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2019/091341 WO2020103439A1 (en) 2018-11-21 2019-06-14 Low-protein serum-free cell culture medium

Country Status (2)

Country Link
CN (1) CN109234223B (en)
WO (1) WO2020103439A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113234662A (en) * 2021-05-08 2021-08-10 康妍葆(北京)干细胞科技有限公司 Stem cell serum-free culture medium and preparation method and application thereof

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109234223B (en) * 2018-11-21 2021-01-19 南京基蛋生物医药有限公司 Low-protein serum-free cell culture medium
CN110117573A (en) * 2019-04-15 2019-08-13 河北省科学院生物研究所 A kind of serum-free cell culture medium and its application
CN115537378B (en) * 2022-11-24 2023-05-19 天信和(苏州)生物科技有限公司 Method for suspension culture of HEK293 cells and culture medium thereof
CN116515737B (en) * 2023-06-28 2023-09-22 苏州依科赛生物科技股份有限公司 HEK293 cell and CHO cell universal culture medium and application thereof

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1778902A (en) * 2005-09-29 2006-05-31 华东理工大学 Non-serum culture medium for multiple animal cell large-scale culture
CN106062205A (en) * 2013-12-20 2016-10-26 基本药品有限责任公司 Media for cell culture
CN107043738A (en) * 2017-02-07 2017-08-15 韶关学院 A kind of porcine hepatocyte serum free medium and preparation method thereof
CN109234223A (en) * 2018-11-21 2019-01-18 南京基蛋生物医药有限公司 Low albumen serum-free cell culture medium

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2990805B2 (en) * 1990-12-27 1999-12-13 吉富製薬株式会社 Serum-free medium, method for culturing animal cells, and method for producing heterologous protein
CN1269956C (en) * 2004-02-17 2006-08-16 华东理工大学 Non serum substratum for in vitro culture and amplification of cutaneous keratin cell
CN1962857A (en) * 2005-11-11 2007-05-16 上海中科伍佰豪生物工程有限公司 Serum-free medium for mammalian cell
CN101760442B (en) * 2010-01-15 2012-06-27 华东理工大学 Serum-free medium for MDCK cell large-scale adherent culture and single-cell suspension culture
WO2011140397A2 (en) * 2010-05-05 2011-11-10 The Regents Of The University Of California Office Of The President Stem cell defined media for xeno-free and feeder free conditions and uses thereof
CN105886465A (en) * 2014-11-15 2016-08-24 赵宇 Serum substitute for immune cell suspension culture
CN105112363B (en) * 2015-08-18 2019-03-29 广东美赛尔细胞生物科技有限公司 A kind of serum free medium of human adipose mesenchymal stem cells and preparation method thereof
CN107304411A (en) * 2016-04-22 2017-10-31 康思葆(北京)生物技术有限公司 A kind of serum substitute for the culture that suspended for immunocyte
CN107435037B (en) * 2016-05-27 2021-12-21 上海倍谙基生物科技有限公司 Serum-free medium for BHK (baby hamster kidney) cells
CN108690825B (en) * 2017-04-06 2021-08-17 上海倍谙基生物科技有限公司 Serum-free medium for protecting integrity of antibody disulfide bonds in animal cell culture
CN107217036B (en) * 2017-06-05 2020-01-21 辉源生物科技(上海)有限公司 Nerve cell serum-free culture medium and application thereof
CN107099508A (en) * 2017-06-23 2017-08-29 曲宝赤 A kind of Serum-free Hybridoma cell culture medium
CN107365747B (en) * 2017-08-30 2020-06-12 五邑大学 Serum-free tumor stem cell culture medium and application thereof
CN108251360A (en) * 2017-12-25 2018-07-06 西安组织工程与再生医学研究所 A kind of human mesenchymal stem cell serum free medium and its preparation method

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1778902A (en) * 2005-09-29 2006-05-31 华东理工大学 Non-serum culture medium for multiple animal cell large-scale culture
CN106062205A (en) * 2013-12-20 2016-10-26 基本药品有限责任公司 Media for cell culture
CN107043738A (en) * 2017-02-07 2017-08-15 韶关学院 A kind of porcine hepatocyte serum free medium and preparation method thereof
CN109234223A (en) * 2018-11-21 2019-01-18 南京基蛋生物医药有限公司 Low albumen serum-free cell culture medium

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
DUAN, PANPAN ET AL.: "Optimization of Serum-Free Medium for Vero Cells", CHINESE JOURNAL OF BIOLOGICALS, vol. 28, no. 5, 31 May 2015 (2015-05-31), ISSN: 1004-5503 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113234662A (en) * 2021-05-08 2021-08-10 康妍葆(北京)干细胞科技有限公司 Stem cell serum-free culture medium and preparation method and application thereof

Also Published As

Publication number Publication date
CN109234223B (en) 2021-01-19
CN109234223A (en) 2019-01-18

Similar Documents

Publication Publication Date Title
WO2020103439A1 (en) Low-protein serum-free cell culture medium
CN103060264B (en) Stem cell culture medium and application thereof and stem cell cultivation method
Kishishita et al. Optimization of chemically defined feed media for monoclonal antibody production in Chinese hamster ovary cells
CN101418330B (en) Non protein culture medium adapted to large-scale culture of NSO cell and production of antibody
CN101760442A (en) Serum-free medium for MDCK cell large-scale adherent culture and single-cell suspension culture
CN110934132A (en) Serum-free DMSO-free cell cryopreservation liquid and preparation method thereof
CN112795531B (en) CHO cell serum-free and protein-free culture medium and application thereof
CN101988047B (en) Insect cell serum-free medium with low cost
CN101603026A (en) Be suitable for the animal origin-free low-protein culture medium of zooblast products production
CN107267462B (en) Serum-free culture medium for inducing pluripotent stem cells to rapidly generate
CN1778902A (en) Non-serum culture medium for multiple animal cell large-scale culture
JP6990659B2 (en) Chemically defined medium for culturing cancer stem cell (CSC) -containing cell populations
CN109370985A (en) A kind of human umbilical cord mesenchymal stem cells large-scale culture serum free medium
CN105838675A (en) Hematopoietic stem cell serum-free culture medium
CN105462911B (en) Serum-free medium for cultivating virus and preparation method thereof
JP6108170B2 (en) Cell culture media
CN104726400B (en) Non-animal derived component cultural method of the human pluripotent stem cells to germline
CA2111984A1 (en) Iron chelate culture medium additive
EP4092046A1 (en) Cell culture medium composition
CN109337866A (en) A kind of fat stem cell serum free medium
CN116751735B (en) Serum-free culture method of umbilical cord mesenchymal stem cells
CN114645010A (en) Low-protein serum-free cell culture medium for producing monoclonal antibody and application thereof
CN107384871A (en) It is a kind of to be used to cultivate culture medium of virus and preparation method thereof
CN109988741B (en) Serum substitute for cell culture, preparation method thereof, serum substitute composition for cell culture and cell culture medium
JP2800338B2 (en) Preparation method of serum-free medium for cell culture

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 19887661

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 19887661

Country of ref document: EP

Kind code of ref document: A1